Gilead Sciences' HIV Drug
Gilead Sciences is working with the South African government to produce HIV prevention drug lenacapavir. The company is partnering with the World Health Organization.
Amara Diallo
Senior Africa Correspondent
Introduction to Lenacapavir
Gilead Sciences is working with the South African government to come to an agreement that would enable the local production of HIV prevention drug lenacapavir. The company is partnering with the World Health Organization.
Production Plans
The details of the agreement are not specified, but the partnership aims to increase access to the life-saving medication. Gilead Sciences is known for its work in HIV prevention and treatment.
RELATED READING
SOURCES & REFERENCES
This article was researched and compiled by the PulseAfrica editorial team using information from international news sources including Reuters, BBC Africa, Al Jazeera, AFP, and local African media outlets. PulseAfrica is committed to accurate, balanced and independent journalism covering all 54 African nations in three languages.
